Star
Star
Star
Star
Star
Star
Star
Solution

Licensing & deal structuring

We build licensing constructs and economics that balance risk, upside, and strategic control.

Designing deal terms that match your strategy

We step in once partners are genuinely engaged—when interest needs to turn into concrete options, numbers, and governance. Building on the BD work, we translate appetite into structured licensing and co-development scenarios that reflect scientific risk, access potential, and your long-term role in the asset.

From interest to structured options

We take what we’re hearing in meetings and diligence—territories, indications, co-dev appetite, timelines—and shape it into a small set of realistic deal scenarios. Global vs regional, straight licensing vs options, co-dev vs pure commercial rights: each comes with clear implications for costs, timelines, and upside so you’re not negotiating in the dark.

Economics and governance you can stand behind

We construct high-level deal models covering upfronts, milestones, royalties, and profit shares, anchored in precedent deals and the asset’s evidence and access outlook. In parallel, we outline alliance governance: who decides what, how joint committees work, which KPIs matter, and how to keep obligations deliverable. When legal and external advisors step in, they work from a coherent, strategy-aligned starting point instead of a blank page.

Key areas of licensing & deal structuring

  • Deal model & valuation scenarios – Upfront, milestone, royalty and profit-share ranges tied to risk, market size, and partner role.

  • Structure selection – Comparing options (global vs regional, option-to-license, co-dev/co-promotion, distribution) with pros/cons and trigger events.

  • Term sheet drafting support – Strategy-aligned term sheet outlines, red-line guidance, and issue lists to work through with legal counsel.

  • Alliance & governance design – Strawman for joint committees, decision rights, reporting, performance expectations, and escalation paths.

  • Negotiation preparation & internal alignment – Walk-away points, trade-off levers, scenario packs, and a shared internal view of what “good” looks like before you enter the room.

“Strong deals balance scientific risk, strategic fit, and shared upside—long before the lawyers touch the contract.”

With structured licensing and deal options in place, you go into negotiations clear on which structures you prefer, where you can flex, and what must be protected, turning partner interest into durable, value-creating agreements.

Designing deal terms that match your strategy

We step in once partners are genuinely engaged—when interest needs to turn into concrete options, numbers, and governance. Building on the BD work, we translate appetite into structured licensing and co-development scenarios that reflect scientific risk, access potential, and your long-term role in the asset.

From interest to structured options

We take what we’re hearing in meetings and diligence—territories, indications, co-dev appetite, timelines—and shape it into a small set of realistic deal scenarios. Global vs regional, straight licensing vs options, co-dev vs pure commercial rights: each comes with clear implications for costs, timelines, and upside so you’re not negotiating in the dark.

Economics and governance you can stand behind

We construct high-level deal models covering upfronts, milestones, royalties, and profit shares, anchored in precedent deals and the asset’s evidence and access outlook. In parallel, we outline alliance governance: who decides what, how joint committees work, which KPIs matter, and how to keep obligations deliverable. When legal and external advisors step in, they work from a coherent, strategy-aligned starting point instead of a blank page.

Key areas of licensing & deal structuring

  • Deal model & valuation scenarios – Upfront, milestone, royalty and profit-share ranges tied to risk, market size, and partner role.

  • Structure selection – Comparing options (global vs regional, option-to-license, co-dev/co-promotion, distribution) with pros/cons and trigger events.

  • Term sheet drafting support – Strategy-aligned term sheet outlines, red-line guidance, and issue lists to work through with legal counsel.

  • Alliance & governance design – Strawman for joint committees, decision rights, reporting, performance expectations, and escalation paths.

  • Negotiation preparation & internal alignment – Walk-away points, trade-off levers, scenario packs, and a shared internal view of what “good” looks like before you enter the room.

“Strong deals balance scientific risk, strategic fit, and shared upside—long before the lawyers touch the contract.”

With structured licensing and deal options in place, you go into negotiations clear on which structures you prefer, where you can flex, and what must be protected, turning partner interest into durable, value-creating agreements.

We align BioPharma innovation, capital, and strategy cross borders.

We connect visionary researchers and impact-driven investors to shape the future of healthcare.

We align BioPharma innovation, capital, and strategy cross borders.

We connect visionary researchers and impact-driven investors to shape the future of healthcare.

We align BioPharma innovation, capital, and strategy cross borders.

We connect visionary researchers and impact-driven investors to shape the future of healthcare.

Logo

Deep domain expertise. Better BioPharma deals

Where Visionaries Shape The Future And Leave a Lasting Legacy

© Jarlen Capital powered by Sphere Corporate